Previous 10 | Next 10 |
IRVINE, Calif. , May 7, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced updates from its annual meeting, in which Edwards' stockholders voted ...
Introduction This article is a follow-up to a series of articles I recently wrote about how to avoid losses and how to profit from sentiment cycles. If you are already familiar with the strategy, feel free to skip down to the "Free Share Gain Winners" section and read from there. If you ar...
IRVINE, Calif. , May 5, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to participate in two upcoming investor conferences. On May 13,...
Edwards Lifesciences (NYSE: EW) shares rose 15.3% in April, according to data provided by S&P Global Market Intelligence . The S&P 500 index rebounded 13% in April after entering a bear market a month earlier. Edwards Lifesciences, like many other companies across industries...
Adverum Biotechnologies (NASDAQ: ADVM ) initiated with Buy rating and $17 (36% upside) price target at Goldman Sachs. More news on: Adverum Biotechnologies, Inc., Alector, Inc., Alexion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Edwards Lifesciences’ ( EW ) is one of the many stocks which spiralled down in late February and March 2020. Although the company has managed to positively surprise the market in the first quarter, the ongoing COVID-19 pandemic is bound to take a toll on its financials in the short run....
IRVINE, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that Health Canada approved an expanded indication for use of the HemoS...
Mylan Gets European Union Nod for Upjohn Merger Mylan NV ( MYL ) reported that the European Union has given its approval to the company's merger with Pfizer’s ( PFE ) Upjohn. However, this antitrust clearance comes with certain caveats such as the offloading of certain assets. The E...
Like nearly every stock, Edwards Lifesciences (NYSE: EW) tanked during the coronavirus-driven stock market sell-off in late February and March. But its shares have bounced back more robustly than most stocks. The healthcare company announced its first-quarter results after the ma...
Edwards Lifesciences Corporation (EW) Q1 2020 Results Conference Call April 23, 2020 5:00 PM ET Company Participants Mark Wilterding - VP, IR Mike Mussallem - Chairman & CEO Scott Ullem - CFO Conference Call Participants Bob Hopkins - Bank of America David Lewis - Mo...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Vancouver, British Columbia--(Newsfile Corp. - July 30, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to provide this update in regard to the status of the proposed return of capital announced on June 19, 2024 . The Company has prepared and mailed its ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 1.7% to $112.28 on volume of 455,296,152 shares Ford Motor Company (F) fell 18.4% to $11.16 on volume of 256,384,806 shares PROSHARES TRUST (SQQQ) rose 3.4% to $9.37 on volume of 246,885,889 shares Sel...
2024-07-25 16:00:08 ET Pito Chickering from Deutsche Bank issued a price target of $85.00 for EW on 2024-07-25 13:36:00. The adjusted price target was set to $85.00. At the time of the announcement, EW was trading at $60.58. The overall price target consensus is at $109....